CLEVELAND, Ohio — A shift toward personalized treatment for breast cancer, ways to help patients live longer without their cancer worsening and a shorter but equally effective treatment for a ...
Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...
In this study, researchers aimed to determine whether the addition of durvalumab to gemcitabine plus cisplatin increases time toxicity.
Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...
A triple drug approach that blocks the KRAS pathway at three points eliminated pancreatic tumors and prevented resistance in ...
Patients with leptomeningeal metastasis (LM) have historically had few treatment options. Now, researchers from The ...
Groundbreaking cancer treatment is taking place at Albany Medical Center. New York Oncology Hematology offering CAR-T therapy, which stands for chimeric antigen receptor T-cell therapy. This treatment ...
A breakthrough in CAR-T therapy may allow cancer treatment with a single injection, cutting costs and making care more available.
Jodhpur: AIIMS Jodhpur is hosting a two-day national conference, Nextgen Oncology on March 21 and 22 at its E-Classroom, bringing together leading cancer care specialists from across the country.The ...
A new treatment for advanced skin cancer has been released. Melanoma is a dangerous type of skin cancer that presents as unusual moles, sores and lumps. New therapeutic advances for metastatic ...
MedPage Today on MSN
Cancer vaccines dogged by misinformation; 867-5309 for cancer; bee venom as therapy?
News, features, and commentary about cancer-related issues ...
Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. For years prior, she’d had ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results